Prognostic factors influencing survival following re-resection for isocitrate dehydrogenase (IDH) -wildtype glioblastoma multiforme – Data from a national neuro-oncology registry

2022 ◽  
Vol 95 ◽  
pp. 142-150
Author(s):  
Maeve A. Hennessy ◽  
Zachary L. Coyne ◽  
Philip J. O'Halloran ◽  
William Mullally ◽  
Mohamed Dablouk ◽  
...  
2020 ◽  
Vol 27 (17) ◽  
pp. 2814-2825
Author(s):  
Francesco Fiorica ◽  
Maria Colella ◽  
Rosaria Taibi ◽  
Andrea Bonetti ◽  
Jacopo Giuliani ◽  
...  

: Glioblastoma multiforme (GBM) is characterized by poor prognosis despite an aggressive therapeutic strategy. In recent years, many advances have been achieved in the field of glioblastoma biology. : Here we try to summarize the main clinical and biological factors impacting clinical prognostication and therapy of GBM patients. From that standpoint, hopefully, in the near future, personalized therapies will be available.


Neoplasma ◽  
2014 ◽  
Vol 61 (04) ◽  
pp. 433-438 ◽  
Author(s):  
H. KAYA ◽  
C. SEZGİ ◽  
A. C. TANRİKULU ◽  
M. TAYLAN ◽  
O. ABAKAY ◽  
...  

2015 ◽  
Vol 49 (3) ◽  
pp. 862-867 ◽  
Author(s):  
Jean-Philippe Delpy ◽  
Pierre-Benoit Pagès ◽  
Pierre Mordant ◽  
Pierre-Emmanuel Falcoz ◽  
Pascal Thomas ◽  
...  

1989 ◽  
Vol 14 (1) ◽  
pp. 61
Author(s):  
Riccardo Valdagni ◽  
Fei-Fei Lui ◽  
Daniel S. Kapp

2007 ◽  
Vol 32 (1) ◽  
pp. 93-103 ◽  
Author(s):  
Marcella Arru ◽  
Luca Aldrighetti ◽  
Renato Castoldi ◽  
Saverio Di Palo ◽  
Elena Orsenigo ◽  
...  

2007 ◽  
Vol 69 (3) ◽  
pp. 820-824 ◽  
Author(s):  
Timothy N. Showalter ◽  
Jocelyn Andrel ◽  
David W. Andrews ◽  
Walter J. Curran ◽  
Constantine Daskalakis ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document